Adam S. Grossman's Securities Transactions in ADMA Biologics, Inc.

Adam S. Grossman, a director and officer of ADMA Biologics, Inc., has reported significant securities transactions. On October 24, 2025, Grossman exercised stock options to acquire 45,000 shares of common stock and received 18,000 shares from the vesting of restricted stock units granted on March 6, 2023. Additionally, Grossman sold 21,000 shares on August 15, 2025, and another 21,000 shares on September 15, 2025, generating gross proceeds of $354,480 and $338,730, respectively. The transactions were executed through Fidelity Brokerage Services, LLC. The aggregate market value of the securities sold is $960,750.